Krumholz Receives the American Heart Association's Clinical Research Prize
Krumholz was recognized “for his work as a founding leader in the field of outcomes research. His work has led to improvements in the quality of care and outcomes for millions of patients nationwide and beyond,” said American Heart Association President Robert A. Harrington, MD, FAHA.
Beta Blockers Reduce Stress-induced Irregular Heart Rhythm
Taking beta blockers — medications that reduce blood pressure and treat many heart conditions — can blunt the negative effects of stress and anger on people with a history of atrial fibrillation, or irregular heart rhythm, said Yale researchers. This strategy could potentially improve quality of life for many of the two million Americans with the condition, according to a new study.
A Better Way to Classify Young Women’s Heart Attacks
A new study, sponsored by Women’s Health Research at Yale, shows how a sex-specific classification system can define and group types of heart attacks that are more common for women. In doing so, the researchers have produced a more accurate guide to treatment and prognosis.
Low mobility predicts hospital readmission in older heart attack patients
Close to 20% of elderly adults who have suffered a heart attack will be readmitted to the hospital within 30 days. Performance on a simple mobility test is the best predictor of whether an elderly heart attack patient will be readmitted, a Yale-led study reports.
Text Messages Show Promise as Next Step for Improving Heart Health in China
Motivational text messages are a well-liked, feasible new way to provide additional support to Chinese patients with heart disease, reports a preliminary study by researchers at Yale and in China. However, the study did not prove that these targeted text messages led to an improvement in blood pressure control amongst the recipients, the intended outcome.
Since 1990s, Heart Attacks Have Become Less Deadly and Frequent for Americans
Heart attack prevention and outcomes have dramatically improved for American adults in the past two decades, according to a Yale study in JAMA Network Open. Compared to the mid-1990s, Americans today are less likely to have heart attacks and also less likely to die from them, said the researchers.
Yale New Haven Becomes First in Connecticut to Perform Pediatric Heart Transplants
Yale New Haven Children’s Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.
Nearly half of adults with heart disease can’t afford their medical bills
More than 45% of non-elderly adults with atherosclerotic cardiovascular disease (ASCVD) report financial hardship due to the associated medical bills, according to a Yale research team. Worse still, about one in five report being unable to pay those medical bills at all, said the researchers.
Krumholz, Spatz receive funding to develop new 24/7 blood pressure monitor
The National Institute of Biomedical Imaging and Bioengineering has awarded a $1.2 million, four-year grant to investigators at Texas A&M University and Yale University for the development of a wrist-worn, cuffless blood pressure monitoring system.
Yale researchers investigate decline in use of preventive defibrillators
In some patients with weak heart muscles, an implantable cardioverter defibrillator, or ICD, can help maintain normal heart rhythm and prolong life. However, concerns about possible overuse of these devices, and a federal investigation, may have led to a recent drop in their use by doctors, a Yale-led study found.
Big data analysis accurately predicts patient survival from heart failure
Heart failure is the leading cause of death and disability in the United States, costing healthcare systems worldwide more than $30 billion annually. Current approaches to treatment are limited by crude clinical assessments of the disease. In a new study, Yale researchers have successfully used big data methods to improve prediction of heart failure patient survival. They also described data-driven categories of patients that are distinct in their response to commonly used therapies.
Study illuminates tiny RNA’s role in heart disease, obesity
A tiny RNA molecule plays a big role in the development of two diseases affecting billions of people worldwide: heart disease and obesity. Yale researchers have found that by disrupting this microRNA in key tissues, they can reduce plaque buildup in arteries while avoiding unintended effects.
Study examines safety of diuretic treatment for heart failure
Each year 1 million Americans are diagnosed with heart failure, a serious condition that causes shortness of breath, weakness, and excess fluid. Diuretics are the main therapy for fluid removal but there has long been concern about potential damage to kidneys with their aggressive use. In a new study, Yale researchers and their co-authors show that this approach may increase serum creatinine levels — a measure of kidney function — but it does not appear to cause kidney injury and may even lead to better outcomes.